Project Grant R50CA293826
Award Date
9/3/24
Completion Date
8/31/29
Dollars Obligated
$160K
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.396, Cancer Biology Research) aims to investigate key transcriptional regulators that drive prostate cancer lineage plasticity, which can lead to more lethal cancer subtypes. The $509,246 award to the Regents of the University of Michigan will fund a 5-year research project to: 1) determine how these transcriptional regulators modulate prostate cancer cell differentiation and hallmarks, 2) understand how the regulators are...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $458,698 to the Regents of the University of Michigan to conduct research aimed at understanding the fundamental biological mechanisms underlying acute myeloid leukemia (AML) relapse. The research will focus on identifying novel gene drivers that confer therapy resistance and contribute to the competitive regrowth of leukemic cells after initial treatment, which is a major barrier...
This Project Grant award, with a total funding amount of $237,023, was provided by the National Cancer Institute (NCI) under the Cancer Biology Research Federal Grant Program (CFDA 93.396). The award supports the development and optimization of a scalable, cost-effective single-cell multi-omic profiling method (SHARE-ME-SEQ) that can jointly capture gene expression, chromatin accessibility, and DNA methylation in acute myeloid leukemia (AML) samples. The goal is to gain unprecedented insights...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $424,264 in funding to the Regents of the University of Michigan from June 1, 2025 to May 31, 2030. The funding will support the development of advanced quantitative analysis methods for long-read RNA sequencing, both at the bulk and single-cell level. The goal is to enable deeper investigations of gene isoforms and their...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) totaling $227,906 will support the development of a novel technology for spatially resolved multi-omics sequencing of formalin-fixed paraffin-embedded (FFPE) tissue samples at the cellular level. The key products and services to be delivered under this award include: Developing spatial epigenome sequencing capabilities to measure gene expression and epigenetic characteristics directly in...
This $1,248,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support the "RARE-CANCER COMMONS: A HUB FOR ACCELERATING INDIVIDUALIZED RARE CANCER THERAPY THROUGH INTEGRATION OF SINGLE-CELL AND CLINICAL GENOMICS DATA" research initiative at the University of Michigan. The project, running from November 1, 2024 to October 31, 2027, will leverage the University's extensive research capabilities to...
The National Cancer Institute (NCI), a component of the Department of Health and Human Services National Institutes of Health, awarded a $101,340 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the Regents of the University of Michigan. The award will fund research to investigate the role of the MS4A14 protein in regulating macrophage activation and antigen presentation, with the goal of improving immunotherapy response in cancer patients. The research...
This federal Project Grant award of $221,456.00 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) aims to develop and optimize a novel approach for enriching microbes from clinical cancer samples to enable deep metaproteomic analysis. The research team, led by the Regents of the University of Minnesota, will pursue two specific aims: 1) Optimize and evaluate the CS-BONCAT (bio-orthogonal non-canonical amino acid tagging) method in samples of known...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $500,719 to the Regents of the University of Michigan to conduct research on the biological mechanisms underlying genetic subtypes of B-cell acute lymphoblastic leukemia (B-ALL) bearing aberrations of the ETV6 gene, including the ETV6-RUNX1 fusion gene. The research will use innovative methods to study the activating mechanisms of GGAA repeat enhancers and their effects on...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) provides funding to support the computational research and platform development activities of a laboratory-based research specialist at the Cleveland Clinic Lerner College of Medicine. The key products and services delivered under this $212,567 award, spanning from September 2024 to August 2029, include: Computational analysis of cancer patient-derived next-generation...